Evidence map›Paper›PMID 36060308›Full record

ArticleMolecular biology2022

Prokaryotic Argonaute Proteins as a Tool for Biotechnology.

E V Kropocheva, L A Lisitskaya, A A Agapov, A A Musabirov, A V Kulbachinskiy, D M Esyunina

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Establishment of a RapidBiosensors · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rapid and Ultrasensitive Detection ofJournal of microbiology and biotechnology · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

E V KropochevaInstitute of Molecular Genetics, National Research Centre "Kurchatov Institute", 123182 Moscow, Russia.
L A LisitskayaInstitute of Molecular Genetics, National Research Centre "Kurchatov Institute", 123182 Moscow, Russia.
A A AgapovInstitute of Molecular Genetics, National Research Centre "Kurchatov Institute", 123182 Moscow, Russia.
A A MusabirovInstitute of Molecular Genetics, National Research Centre "Kurchatov Institute", 123182 Moscow, Russia.
A V KulbachinskiyInstitute of Molecular Genetics, National Research Centre "Kurchatov Institute", 123182 Moscow, Russia.
D M EsyuninaInstitute of Molecular Genetics, National Research Centre "Kurchatov Institute", 123182 Moscow, Russia.
Institute of Molecular Genetics · RUKurchatov Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Programmable nucleases are the most important tool for manipulating the genes and genomes of both prokaryotes and eukaryotes. Since the end of the 20th century, many approaches were developed for specific modification of the genome. The review briefly considers the advantages and disadvantages of the main genetic editors known to date. The main attention is paid to programmable nucleases from the family of prokaryotic Argonaute proteins. Argonaute proteins can recognize and cleave DNA sequences using small complementary guide molecules and play an important role in protecting prokaryotic cells from invading DNA. Argonaute proteins have already found applications in biotechnology for targeted cleavage and detection of nucleic acids and can potentially be used for genome editing.

Indexed as

Argonaute proteinsbiosensorsgenome editingguide DNAprogrammable nucleases

Identifiers

PMID36060308
PMCPMC9427165
OpenAlexW4293685716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.